BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Business

  AMPEL BioSolutions, Horizon Pharma, and Lupus Research Alliance Partner on Unique Clinical Trial for Patients With Lupus

  The RIFLE trial will utilize Horizon Pharma’s proprietary prednisone delayed-release tablets, RAYOS, to address the daily cycling of cortisol and inflammatory mediators known as circadian rhythm.

  December 5, 2017

   · 

  4 min read
• Business

  Sekisui Diagnostics Enters Strategic Alliance With Mesa Biotech for Molecular POC Testing System

  Today, Sekisui Diagnostics and Mesa Biotech announce a strategic alliance, to distribute the Mesa Biotech POC molecular system for Flu A/Flu B.

  December 5, 2017

   · 

  3 min read
• 

  Business

  Purigen Biosystems Appoints Life Science Industry Veteran Barney Saunders, PhD, as CEO

  Dr. Saunders brings 30 years of experience managing emergent technologies and commercializing disruptive products for life science tools and diagnostics companies.

  December 5, 2017

   · 

  2 min read
• BioMidwest

  3M Investment in University of Minnesota Reflects Shared Commitment to STEM and Business Education

  3M’s $26 million investment in the University’s Driven campaign, which spans a 10-year period, includes a new $8 million commitment to support scholarships and outreach programs.

  December 5, 2017

   · 

  2 min read
• Drug Development

  Immunovaccine Announces Positive Clinical Data from Its Collaborative Combination Immunotherapy Trial in Advanced Ovarian Cancer

  Initial results from ten evaluable patients in the DPX-Survivac plus 100 mg epacadostat dosing cohort demonstrate a disease control rate of 70%.

  December 5, 2017

   · 

  7 min read
• Drug Development

  ObsEva Initiates PROLONG, the Phase IIa Clinical Trial of OBE022 in Preterm Labor

  The PROLONG trial is the first clinical trial of OBE022 in pregnant women presenting with spontaneous preterm labor at gestational ages between 24 and 34 weeks.

  December 5, 2017

   · 

  7 min read
• Drug Development

  Neuralstem Presents Positive Updated Data from Phase II Study of NSI-189 in Major Depressive Disorder at the 56th American College of Neuropsychopharmacology (ACNP) Annual Meeting

  These additional results suggest that NSI-189 has antidepressant effects with cognitive benefits shown on both objective and subjective measures.

  December 5, 2017

   · 

  7 min read
• 

  BioForest

  Neuropace’s Brain Implant Reduces Epilepsy Seizures in 8-Year Trial

  Key findings from these prospective trials demonstrate sustained, long-term patient benefits.

  December 5, 2017

   · 

  4 min read
• Pharm Country

  OncLive Presents State of the Science Summit: Hematologic Malignancies

  OncLive, a leading digital provider of resources and information for oncology professionals, presents the latest State of the Science Summit on Hematologic Malignancies at the W Hotel San Francisco on Dec. 16 from 9:00 a.m. to 1:00 p.m.

  December 5, 2017

   · 

  2 min read
• Business

  Plasticell and Anthony Nolan to Partner in Clinical Trials of Ex Vivo Expanded Cord Blood Stem Cells

  The project is part of Plasticell’s hematopoietic cell therapy portfolio, which includes the expansion of hematopoietic stem cells and the manufacture of various blood cell types from pluripotent cell sources.

  December 5, 2017

   · 

  3 min read